高盛：金斯瑞生物科技-2025 年中国医疗企业日-关键要点

24 June 2025 | 4:26PM HKT Genscript Biotech Corp. (1548.HK): China Healthcare Corporate Day 2025 — Expect steadily improving bottom line with ProBio recovering Presenters: Josie Zhou - Chief Financial Officer, Pengfei Duan - Investor Relations Director Bottom line: Mgmt highlighted: 1) ProBio bottoming out, upfront from LaNova deal booked, 2) protein to be the 2nd growth engine for life science group (LSG), and 3) expect steadily improving bottom line, share buybacks/dividends under consideration Key Takeaw ...